Wolfram Hofmann

Title: Wolfram Hofmann: Innovator in Pharmaceutical Science

Introduction

Wolfram Hofmann is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug delivery systems. His work has led to advancements that enhance the efficacy and tolerability of medications.

Latest Patents

Hofmann holds a patent for "Intramuscular injection forms of gyrase inhibitors." This patent details that ciprofloxacin and related gyrase inhibitors are well-tolerated when administered intramuscularly. The invention describes the use of an aqueous suspension of the betaine form with an approximate neutral pH value or an oily suspension of the betaine or its salts. The oily suspensions, which contain the active material in a water-soluble form, can release the active compound rapidly, especially when the wettability of the oily carrier medium is improved by adding interfacially surface-active materials. This innovation represents a significant step forward in the administration of antibiotics.

Career Highlights

Wolfram Hofmann is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Hofmann has worked alongside notable colleagues such as Norbert Pollinger and Peter Serno. Their combined expertise has fostered an environment of innovation and has led to the successful development of new pharmaceutical solutions.

Conclusion

Wolfram Hofmann's contributions to pharmaceutical science, particularly through his patent on intramuscular injection forms of gyrase inhibitors, highlight his role as an innovator in the field. His work continues to influence the way medications are administered and tolerated by patients.